Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080

This publication has 29 references indexed in Scilit:

• Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets
  British Journal of Pharmacology, 1999
• Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic beta-Cells: Blocking of K+ Channels, Mobilization of Ca2+ from Endoplasmic Reticulum, and Interaction with Exocytotic Machinerya
  Annals of the New York Academy of Sciences, 1999
• A History of Naunyn-Schmiedeberg’s Archives of Pharmacology
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
• Imidazoline Compounds Stimulate Insulin Release by Inhibition of KATP Channels and Interaction With the Exocytotic Machinery
  Diabetes, 1996
• Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus‐response coupling of insulin release
  British Journal of Pharmacology, 1996
• Potassium Channels, Imidazolines, and Insulin‐Secreting Cells^fn1
  Annals of the New York Academy of Sciences, 1995
• Imidazoline antagonists of α₂‐adrenoceptors increase insulin release in vitro by inhibiting ATP‐sensitive K⁺ channels in pancreatic β‐cells
  British Journal of Pharmacology, 1992
• The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells
  European Journal of Pharmacology, 1991
• Phentolamine and yohimbine inhibit ATP‐sensitive K+ channels in mouse pancreatic β‐cells
  British Journal of Pharmacology, 1990
• Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels
  European Journal of Pharmacology, 1990